Phosphorylation of extracellular domain KIT mutants

Stable Identifier
R-HSA-9680248
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Mutations occurring in the fifth Ig-like extracellular domain of KIT (encoded by exon 8 and 9) are insertions, deletions and duplications affecting codons 502-504 (reviewed in Lennartsson and Roonstrand, 2012; Corless et al, 2011). These variants support ligand-independent autophosphorylation and activation of the receptor dimers (Bodemer et al, 2010; Cammenga et al, 2005).

Literature References
PubMed ID Title Journal Year
23073628 Stem cell factor receptor/c-Kit: from basic science to clinical implications

Lennartsson, J, Rönnstrand, L

Physiol. Rev. 2012
19865100 Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations

Bodemer, C, Hermine, O, Palmérini, F, Yang, Y, Grandpeix-Guyodo, C, Leventhal, PS, Hadj-Rabia, S, Nasca, L, Georgin-Lavialle, S, Cohen-Akenine, A, Launay, JM, Barete, S, Feger, F, Arock, M, Catteau, B, Sans, B, Stalder, JF, Skowron, F, Thomas, L, Lorette, G, Plantin, P, Bordigoni, P, Lortholary, O, de Prost, Y, Moussy, A, Sobol, H, Dubreuil, P

J. Invest. Dermatol. 2010
22089421 Gastrointestinal stromal tumours: origin and molecular oncology

Corless, CL, Barnett, CM, Heinrich, MC

Nat. Rev. Cancer 2011
16081693 Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate

Cammenga, J, Horn, S, Bergholz, U, Sommer, G, Besmer, P, Fiedler, W, Stocking, C

Blood 2005
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein tyrosine kinase activity of extracellular domain mutant dimers of KIT [plasma membrane]
Physical Entity
Activity
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created
Cite Us!